Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2006 1
2008 1
2009 3
2010 2
2011 2
2012 6
2013 4
2014 7
2015 6
2016 8
2017 11
2018 10
2019 14
2020 11
2021 13
2022 14
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial.
Balanescu AR, Citera G, Pascual-Ramos V, Bhatt DL, Connell CA, Gold D, Chen AS, Sawyerr G, Shapiro AB, Pope JE, Schulze-Koops H. Balanescu AR, et al. Among authors: pascual ramos v. Ann Rheum Dis. 2022 Nov;81(11):1491-1503. doi: 10.1136/ard-2022-222405. Epub 2022 Aug 3. Ann Rheum Dis. 2022. PMID: 35922124 Free PMC article. Clinical Trial.
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study.
van der Heijde D, Strand V, Tanaka Y, Keystone E, Kremer J, Zerbini CAF, Cardiel MH, Cohen S, Nash P, Song YW, Tegzová D, Gruben D, Wallenstein G, Connell CA, Fleischmann R; ORAL Scan Investigators. van der Heijde D, et al. Arthritis Rheumatol. 2019 Jun;71(6):878-891. doi: 10.1002/art.40803. Epub 2019 Apr 24. Arthritis Rheumatol. 2019. PMID: 30666826 Free PMC article. Clinical Trial.
Lupus in Latin-American patients: lessons from the GLADEL cohort.
Pons-Estel GJ, Catoggio LJ, Cardiel MH, Bonfa E, Caeiro F, Sato E, Massardo L, Molina-Restrepo JF, Toledano MG, Barile-Fabris LA, Amigo MC, Acevedo-Vásquez EM, Abadi I, Wojdyla D, Alarcón-Riquelme ME, Alarcón GS, Pons-Estel BA; GLADEL. Pons-Estel GJ, et al. Lupus. 2015 May;24(6):536-45. doi: 10.1177/0961203314567753. Epub 2015 Feb 18. Lupus. 2015. PMID: 25697768 Review.
Autoimmune hepatitis with giant-cell transformation.
Estradas J, Pascual-Ramos V, Martínez B, Uribe M, Torre A. Estradas J, et al. Among authors: pascual ramos v. Ann Hepatol. 2009 Jan-Mar;8(1):68-70. Ann Hepatol. 2009. PMID: 19221538 Free article. Review.
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort.
González LA, Alarcón GS, Harvey GB, Quintana R, Pons-Estel GJ, Ugarte-Gil MF, Vásquez G, Catoggio LJ, García MA, Borba EF, Da Silva NA, Tavares Brenol JC, Toledano MG, Massardo L, Neira O, Pascual-Ramos V, Amigo MC, Barile-Fabris LA, De La Torre IG, Alfaro-Lozano J, Segami MI, Chacón-Díaz R, Esteva-Spinetti MH, Iglesias-Gamarra A, Pons-Estel BA. González LA, et al. Among authors: pascual ramos v. Lupus. 2023 Apr;32(5):658-667. doi: 10.1177/09612033231163745. Epub 2023 Mar 14. Lupus. 2023. PMID: 36916674
Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety.
Bird P, Bensen W, El-Zorkany B, Kaine J, Manapat-Reyes BH, Pascual-Ramos V, Witcombe D, Soma K, Zhang R, Thirunavukkarasu K. Bird P, et al. Among authors: pascual ramos v. J Clin Rheumatol. 2019 Apr;25(3):115-126. doi: 10.1097/RHU.0000000000000786. J Clin Rheumatol. 2019. PMID: 29794874 Free PMC article. Review.
COVID-19 vaccine hesitancy among Mexican outpatients with rheumatic diseases.
Guaracha-Basáñez G, Contreras-Yáñez I, Álvarez-Hernández E, Román-Montes CM, Meza-López Y Olguín G, Morales-Graciano MJ, Valverde-Hernández SS, Peláez-Ballestas I, Pascual-Ramos V. Guaracha-Basáñez G, et al. Among authors: pascual ramos v. Hum Vaccin Immunother. 2021 Dec 2;17(12):5038-5047. doi: 10.1080/21645515.2021.2003649. Epub 2021 Dec 2. Hum Vaccin Immunother. 2021. PMID: 34856876 Free PMC article.
Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path.
Guaracha-Basáñez GA, Contreras-Yáñez I, Hernández-Molina G, Estrada-González VA, Pacheco-Santiago LD, Valverde-Hernández SS, Galindo-Donaire JR, Peláez-Ballestas I, Pascual-Ramos V. Guaracha-Basáñez GA, et al. Among authors: pascual ramos v. PLoS One. 2022 Jan 18;17(1):e0262756. doi: 10.1371/journal.pone.0262756. eCollection 2022. PLoS One. 2022. PMID: 35041692 Free PMC article. Clinical Trial.
104 results